πŸ‡ΊπŸ‡Έ FDA
Patent

US 11098100

Therapeutic compounds and methods

granted A61KA61K38/00A61P

Quick answer

US patent 11098100 (Therapeutic compounds and methods) held by Regents of the University of Minnesota expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61P, A61P35/00, A61P35/02